272 related articles for article (PubMed ID: 8932871)
21. Transplantation of CD34+ hematopoietic progenitor cells.
Shpall EJ; Jones RB; Bearman SI; Purdy MH; Franklin WA; Heimfeld S; Berenson RJ
J Hematother; 1994; 3(2):145-7. PubMed ID: 7522899
[TBL] [Abstract][Full Text] [Related]
22. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow micrometastases in chemotherapy-responsive advanced breast cancer: effect of ex vivo purging with 4-hydroperoxycyclophosphamide.
Passos-Coelho J; Ross AA; Davis JM; Huelskamp AM; Clarke B; Noga SJ; Davidson NE; Kennedy MJ
Cancer Res; 1994 May; 54(9):2366-71. PubMed ID: 8162582
[TBL] [Abstract][Full Text] [Related]
24. Predictive factors for peripheral-blood progenitor-cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte-macrophage colony-stimulating factor mobilization.
Passos-Coelho JL; Braine HG; Davis JM; Huelskamp AM; Schepers KG; Ohly K; Clarke B; Wright SK; Noga SJ; Davidson NE
J Clin Oncol; 1995 Mar; 13(3):705-14. PubMed ID: 7533827
[TBL] [Abstract][Full Text] [Related]
25. [High-dose chemotherapy with autologous peripheral blood stem cell transplantation support in a patient with breast cancer metastasis to bone marrow: immunocytochemical monitoring of cancer-cell contamination].
Uno H; Fujita M; Hino N; Nakagawa H; Miyagawa H; Aoki J; Taniyama K; Sasaki N
Rinsho Ketsueki; 1999 Jul; 40(7):556-62. PubMed ID: 10483138
[TBL] [Abstract][Full Text] [Related]
26. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
27. Positive selection of autologous peripheral blood stem cells.
Lopez M; Beaujean F
Baillieres Best Pract Res Clin Haematol; 1999; 12(1-2):71-86. PubMed ID: 11000984
[TBL] [Abstract][Full Text] [Related]
28. Ex vivo expansion of bone marrow from breast cancer patients: reduction in tumor cell content through passive purging.
Lundell BI; Vredenburgh JJ; Tyer C; DeSombre K; Smith AK
Bone Marrow Transplant; 1998 Jul; 22(2):153-9. PubMed ID: 9707023
[TBL] [Abstract][Full Text] [Related]
29. [Expression of AC133 vs. CD34 in acute childhood leukemias].
Ebener U; Brinkmann A; Zotova V; Niegemann E; Wehner S
Klin Padiatr; 2000; 212(3):90-8. PubMed ID: 10916777
[TBL] [Abstract][Full Text] [Related]
30. Detection of tumor cells in leukapheresis products from patients with breast cancer using immunocytochemical staining method.
Lin YS; Zhong XY; Hohaus S; Kaul S; Haas R
Arch Gynecol Obstet; 2000 Feb; 263(3):119-25. PubMed ID: 10763840
[TBL] [Abstract][Full Text] [Related]
31. Immunomagnetic selection of CD34+ peripheral blood stem cells for autografting in patients with breast cancer.
Hohaus S; Pförsich M; Murea S; Abdallah A; Lin YS; Funk L; Voso MT; Kaul S; Schmid H; Wallwiener D; Haas R
Br J Haematol; 1997 Jun; 97(4):881-8. PubMed ID: 9217192
[TBL] [Abstract][Full Text] [Related]
32. Improvement of breast cancer cell detection by immunomagnetic enrichment.
Krüger W; Tögel F; Rössing S; Kröger N; Zander AR
Cytotherapy; 1999; 1(2):135-9. PubMed ID: 19746590
[TBL] [Abstract][Full Text] [Related]
33. Peripheral blood CD34+ cell immunomagnetic selection in breast cancer patients: effect on hematopoietic progenitor content and hematologic recovery after high-dose chemotherapy and autotransplantation.
Cancelas JA; Querol S; Canals C; Picón M; Azqueta C; Solà C; Montes A; Amill B; Griera E; Inglés J; López JJ; Germà JR; García-López J
Transfusion; 1998; 38(11-12):1063-70. PubMed ID: 9838939
[TBL] [Abstract][Full Text] [Related]
34. Shiga-like toxin-1 receptor on human breast cancer, lymphoma, and myeloma and absence from CD34(+) hematopoietic stem cells: implications for ex vivo tumor purging and autologous stem cell transplantation.
LaCasse EC; Bray MR; Patterson B; Lim WM; Perampalam S; Radvanyi LG; Keating A; Stewart AK; Buckstein R; Sandhu JS; Miller N; Banerjee D; Singh D; Belch AR; Pilarski LM; Gariépy J
Blood; 1999 Oct; 94(8):2901-10. PubMed ID: 10515895
[TBL] [Abstract][Full Text] [Related]
35. Purging of tumor cells from leukapheresis products: experimental and clinical aspects.
Kvalheim G; Wang MY; Pharo A; Holte H; Jacobsen E; Beiske K; Kvaløy S; Smeland E; Funderud S; Fodstad O
J Hematother; 1996 Aug; 5(4):427-36. PubMed ID: 8877718
[TBL] [Abstract][Full Text] [Related]
36. Mobilization of tumor cells and hematopoietic progenitor cells into peripheral blood of patients with solid tumors.
Brugger W; Bross KJ; Glatt M; Weber F; Mertelsmann R; Kanz L
Blood; 1994 Feb; 83(3):636-40. PubMed ID: 7507729
[TBL] [Abstract][Full Text] [Related]
37. In vivo purging with rituximab prior to collection of stem cells for autologous transplantation in chronic lymphocytic leukemia.
Berkahn L; Simpson D; Raptis A; Klingemann HG
J Hematother Stem Cell Res; 2002 Apr; 11(2):315-20. PubMed ID: 11983102
[TBL] [Abstract][Full Text] [Related]
38. Absence of breast cancer cells in a single-day peripheral blood progenitor cell collection after priming with cyclophosphamide and granulocyte-macrophage colony-stimulating factor.
Passos-Coelho JL; Ross AA; Moss TJ; Davis JM; Huelskamp AM; Noga SJ; Davidson NE; Kennedy MJ
Blood; 1995 Feb; 85(4):1138-43. PubMed ID: 7849302
[TBL] [Abstract][Full Text] [Related]
39. Immunocytochemical detection of breast cancer cells: a comparison of three attachment factors.
Theocharous P; Lowdell MW; Jones AL; Prentice HG
J Hematother; 1997 Feb; 6(1):21-9. PubMed ID: 9112215
[TBL] [Abstract][Full Text] [Related]
40. Positive selection and transplantation of peripheral CD34+ progenitor cells: feasibility and purging efficacy in pediatric patients with neuroblastoma.
Handgretinger R; Greil J; Schürmann U; Lang P; Gonzalez-Ramella O; Schmidt I; Führer R; Niethammer D; Klingebiel T
J Hematother; 1997 Jun; 6(3):235-42. PubMed ID: 9234178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
